| Item Type | Name |
|
Academic Article
|
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B.
|
|
Academic Article
|
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.
|
|
Academic Article
|
Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site.
|
|
Academic Article
|
Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.
|
|
Academic Article
|
The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication.
|
|
Academic Article
|
Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.
|
|
Academic Article
|
Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor.
|
|
Academic Article
|
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.
|
|
Academic Article
|
Design of HIV-1 protease inhibitors active on multidrug-resistant virus.
|
|
Academic Article
|
PTEN enters the nucleus by diffusion.
|
|
Academic Article
|
Crystallization of human thymidylate synthase.
|
|
Academic Article
|
Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.
|
|
Academic Article
|
Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease.
|
|
Academic Article
|
Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling.
|
|
Academic Article
|
Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres.
|
|
Academic Article
|
Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3.
|
|
Academic Article
|
Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5.
|
|
Academic Article
|
Viral protease inhibitors.
|
|
Academic Article
|
Toward the design of mutation-resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis.
|
|
Academic Article
|
Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces.
|
|
Academic Article
|
Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease.
|
|
Academic Article
|
Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sites.
|
|
Academic Article
|
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.
|
|
Academic Article
|
Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones.
|
|
Academic Article
|
Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease.
|
|
Academic Article
|
Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope.
|
|
Academic Article
|
The challenge of developing robust drugs to overcome resistance.
|
|
Academic Article
|
Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.
|
|
Academic Article
|
First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.
|
|
Academic Article
|
Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
|
|
Academic Article
|
Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A.
|
|
Academic Article
|
The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors.
|
|
Academic Article
|
Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket.
|
|
Academic Article
|
Nitric oxide-mediated inhibition of Hdm2-p53 binding.
|
|
Academic Article
|
Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy.
|
|
Academic Article
|
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.
|
|
Academic Article
|
Covariation of amino acid positions in HIV-1 protease.
|
|
Academic Article
|
Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.
|
|
Academic Article
|
Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease.
|
|
Academic Article
|
Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance.
|
|
Academic Article
|
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.
|
|
Academic Article
|
Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity.
|
|
Academic Article
|
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.
|
|
Academic Article
|
Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease.
|
|
Academic Article
|
Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease.
|
|
Academic Article
|
Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.
|
|
Academic Article
|
Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.
|
|
Academic Article
|
Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
|
|
Academic Article
|
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.
|
|
Academic Article
|
Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
|
|
Academic Article
|
Therapeutic targeting of C-terminal binding protein in human cancer.
|
|
Academic Article
|
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding.
|
|
Academic Article
|
Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacity.
|
|
Academic Article
|
TMC310911, a novel human immunodeficiency virus type 1 protease inhibitor, shows in vitro an improved resistance profile and higher genetic barrier to resistance compared with current protease inhibitors.
|
|
Academic Article
|
Decomposing the energetic impact of drug-resistant mutations: the example of HIV-1 protease-DRV binding.
|
|
Academic Article
|
Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease.
|
|
Academic Article
|
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance.
|
|
Academic Article
|
Structural and thermodynamic basis of amprenavir/darunavir and atazanavir resistance in HIV-1 protease with mutations at residue 50.
|
|
Academic Article
|
Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.
|
|
Academic Article
|
Interview with Celia Schiffer.
|
|
Academic Article
|
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.
|
|
Academic Article
|
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583.
|
|
Concept
|
pol Gene Products, Human Immunodeficiency Virus
|
|
Concept
|
Humans
|
|
Concept
|
Human Growth Hormone
|
|
Concept
|
Influenza, Human
|
|
Concept
|
Enterovirus D, Human
|
|
Concept
|
gag Gene Products, Human Immunodeficiency Virus
|
|
Concept
|
Human T-lymphotropic virus 1
|
|
Concept
|
Chromosomes, Human, Pair 21
|
|
Concept
|
Chromosomes, Human, Pair 8
|
|
Concept
|
vif Gene Products, Human Immunodeficiency Virus
|
|
Academic Article
|
Influenza virus drug resistance: a time-sampled population genetics perspective.
|
|
Academic Article
|
Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3/4A protease inhibitors to drug resistance.
|
|
Academic Article
|
A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid.
|
|
Academic Article
|
Testing the substrate-envelope hypothesis with designed pairs of compounds.
|
|
Academic Article
|
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.
|
|
Academic Article
|
Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.
|
|
Academic Article
|
HIV-1 protease-substrate coevolution in nelfinavir resistance.
|
|
Academic Article
|
Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease.
|
|
Academic Article
|
A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.
|
|
Academic Article
|
Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs.
|
|
Academic Article
|
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.
|
|
Academic Article
|
Structure-guided design of a high affinity inhibitor to human CtBP.
|
|
Academic Article
|
REdiii: a pipeline for automated structure solution.
|
|
Academic Article
|
Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.
|
|
Academic Article
|
A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.
|
|
Academic Article
|
Structural basis for mutation-induced destabilization of profilin 1 in ALS.
|
|
Academic Article
|
Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy.
|
|
Academic Article
|
A Balance between Inhibitor Binding and Substrate Processing Confers Influenza Drug Resistance.
|
|
Academic Article
|
Inhibition of APOBEC3G activity impedes double-stranded DNA repair.
|
|
Academic Article
|
Improving Viral Protease Inhibitors to Counter Drug Resistance.
|
|
Academic Article
|
Dengue Protease Substrate Recognition: Binding of the Prime Side.
|
|
Academic Article
|
Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1.
|
|
Academic Article
|
Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions.
|
|
Academic Article
|
Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 Neuraminidase.
|
|
Academic Article
|
Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
|
|
Academic Article
|
Interdependence of Inhibitor Recognition in HIV-1 Protease.
|
|
Academic Article
|
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants.
|
|
Academic Article
|
Elucidating the Interdependence of Drug Resistance from Combinations of Mutations.
|
|
Academic Article
|
Structural Determination of the Broadly Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope.
|
|
Academic Article
|
Synonymous Mutations at the Beginning of the Influenza A Virus Hemagglutinin Gene Impact Experimental Fitness.
|
|
Academic Article
|
Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.
|
|
Academic Article
|
Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
|
|
Academic Article
|
Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease.
|
|
Academic Article
|
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response.
|
|
Academic Article
|
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B.
|
|
Academic Article
|
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.
|
|
Academic Article
|
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.
|
|
Academic Article
|
A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia.
|
|
Academic Article
|
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
|
|
Academic Article
|
Assembly of human C-terminal binding protein (CtBP) into tetramers.
|
|
Academic Article
|
Mavyret: A Pan-Genotypic Combination Therapy for the Treatment of Hepatitis C InfectionPublished as part of the Biochemistry series "Biochemistry to Bedside".
|
|
Academic Article
|
A call to arms: Unifying the fight against resistance.
|
|
Academic Article
|
Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.
|
|
Academic Article
|
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.
|
|
Academic Article
|
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
|
|
Academic Article
|
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia.
|
|
Academic Article
|
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.
|
|
Academic Article
|
Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors.
|
|
Academic Article
|
APOBEC3s: DNA-editing human cytidine deaminases.
|
|
Academic Article
|
NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations.
|
|
Academic Article
|
Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.
|
|
Academic Article
|
Target-Specific Prediction of Ligand Affinity with Structure-Based Interaction Fingerprints.
|
|
Academic Article
|
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.
|
|
Academic Article
|
Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance.
|
|
Academic Article
|
Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.
|
|
Academic Article
|
Characterizing Protein-Ligand Binding Using Atomistic Simulation and Machine Learning: Application to Drug Resistance in HIV-1 Protease.
|
|
Academic Article
|
Optimizing the refinement of merohedrally twinned P61 HIV-1 protease-inhibitor cocrystal structures.
|
|
Academic Article
|
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors.
|
|
Academic Article
|
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.
|
|
Academic Article
|
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
|
|
Academic Article
|
Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.
|
|
Academic Article
|
Cryo-EM structure of CtBP2 confirms tetrameric architecture.
|
|
Academic Article
|
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.
|
|
Academic Article
|
Unique structural solution from a VH3-30 antibody targeting the hemagglutinin stem of influenza A viruses.
|
|
Academic Article
|
NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP).
|
|
Academic Article
|
Inhibiting HTLV-1 Protease: A Viable Antiviral Target.
|
|
Academic Article
|
Introduction: Drug Resistance.
|
|
Academic Article
|
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
|
|
Academic Article
|
Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s.
|
|
Academic Article
|
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.
|
|
Academic Article
|
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
|
|
Academic Article
|
Viral proteases: Structure, mechanism and inhibition.
|
|
Academic Article
|
Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
|
|
Academic Article
|
Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to Avoid Drug Resistance.
|
|
Academic Article
|
Call for Papers: Drug Resistance in Infectious Diseases and Beyond.
|
|
Academic Article
|
Quantitative structural analysis of influenza virus by cryo-electron tomography and convolutional neural networks.
|
|
Academic Article
|
HIV-1 VIF and human APOBEC3G interaction directly observed through molecular specific labeling using a new dual promotor vector.
|
|
Academic Article
|
Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms.
|
|
Academic Article
|
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance.
|
|
Academic Article
|
Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2.
|
|
Academic Article
|
Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
|
|
Academic Article
|
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants.
|
|
Academic Article
|
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance.
|
|
Academic Article
|
Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses.
|
|
Academic Article
|
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease.
|
|
Academic Article
|
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
|
|
Academic Article
|
Chronic lymphocytic leukemia: recommendations.
|
|
Academic Article
|
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
|
|
Academic Article
|
Report of an international working group to standardize response criteria for myelodysplastic syndromes.
|
|
Academic Article
|
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.
|
|
Academic Article
|
Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance.
|
|
Academic Article
|
Myelodysplastic syndromes standardized response criteria: further definition.
|
|
Academic Article
|
Increasing intracellular dNTP levels improves prime editing efficiency.
|
|
Academic Article
|
FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques.
|
|
Academic Article
|
Elucidating the Substrate Envelope of Enterovirus 68-3C Protease: Structural Basis of Specificity and Potential Resistance.
|
|
Academic Article
|
Direct delivery of Cas-embedded cytosine base editors as ribonucleoprotein complexes for efficient and accurate editing of clinically relevant targets.
|
|
Academic Article
|
Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease.
|
|
Academic Article
|
Next generation?APOBEC3 inhibitors: optimally designed for potency and nuclease stability.
|
|
Academic Article
|
Virion-associated influenza hemagglutinin clusters upon sialic acid binding visualized by cryoelectron tomography.
|
|
Academic Article
|
Molecular mechanisms of drug resistance and compensation in SARS-CoV-2 main protease: the interplay between E166 and L50.
|